Recent studies using co-crystal structure assays combined with mutation assays in HT-1080 fibrosarcoma cells, suggest that the region around Cys66 also serves as a covalent binding site for RSL3 and ML162 on GPX4, indicating they have multiple binding sites on GPX4 [93]. Here, GPX4 is linked to fibrosarcoma.